LENSAR Inc
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
LNSR$5.46+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets (Unaudited)
CONDENSED BALANCE SHEETS
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $19,547 | $16,263 |
| Short-term investments | 5,700 | 6,192 |
| Accounts receivable, net of allowance of $85 and $105, respectively | 6,885 | 6,085 |
| Notes receivable, net of allowance of $7 and $8, respectively | 357 | 395 |
| Inventories | 15,324 | 11,428 |
| Prepaid and other current assets | 1,373 | 1,616 |
| Total current assets | 49,186 | 41,979 |
| Property and equipment, net | 577 | 664 |
| Equipment under lease, net | 13,902 | 13,767 |
| Notes and other receivables, long-term, net of allowance of $19 and $23, respectively | 937 | 1,160 |
| Intangible assets, net | 5,880 | 6,112 |
| Other assets | 2,477 | 2,615 |
| Total assets | $72,959 | $66,297 |
| Liabilities, redeemable convertible preferred stock, and stockholders’ (deficit) equity | ||
| Current liabilities: | ||
| Accounts payable | $7,754 | $5,995 |
| Accrued liabilities | 6,910 | 6,807 |
| Deferred revenue | 1,993 | 1,677 |
| Operating lease liabilities | 517 | 524 |
| Acquisition-related deposit | 10,000 | — |
| Total current liabilities | 27,174 | 15,003 |
| Long-term operating lease liabilities | 1,956 | 2,090 |
| Warrant liabilities | 51,570 | 29,856 |
| Other long-term liabilities | 616 | 702 |
| Total liabilities | 81,316 | 47,651 |
| Commitments and contingencies (Note 10) | ||
| Series A Redeemable Convertible Preferred Stock, par value $0.01 per share, 20 shares authorized at March 31, 2025 and December 31, 2024; 20 shares issued and outstanding at March 31, 2025 and December 31, 2024; aggregate liquidation preference of $20,000 at March 31, 2025 and December 31, 2024 | 13,784 | 13,784 |
| Stockholders’ (deficit) equity: | ||
| Preferred stock, par value $0.01 per share, 9,980 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024 | — | — |
| Common stock, par value $0.01 per share, 150,000 shares authorized at March 31, 2025 and December 31, 2024; 11,790 and 11,654 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 118 | 116 |
| Additional paid-in capital | 148,378 | 148,035 |
| Accumulated other comprehensive income | 3 | 6 |
| Accumulated deficit | (170,640) | (143,295) |
| Total stockholders’ (deficit) equity | (22,141) | 4,862 |
| Total liabilities, redeemable convertible preferred stock, and stockholders’ (deficit) equity | $72,959 | $66,297 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.